stockrowMacroGenics, Inc. (MGNX) vs Sutro Biopharma, Inc. (STRO)
- MacroGenics, Inc. MGNX 2.33 +4.95%
- Sutro Biopharma, Inc. STRO 9.62 +4.57%
MacroGenics, Inc. and Sutro Biopharma, Inc. are both Biotechnology companies. MacroGenics, Inc. and Sutro Biopharma, Inc. are of similar size ($159.5M and $148.4M). MacroGenics, Inc. grew revenue faster over the last twelve months: 1.32% against −56.3%. MacroGenics, Inc. has the higher net margin (−8.70% vs −395.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, MacroGenics, Inc. leads on 9 and Sutro Biopharma, Inc. on 6.
Valuation
Profitability
| Metric | MGNX | STRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.23% | 100.00% | 68.51% |
| Operating margin | (20.45%) | (319.57%) | 0.00% |
| Net margin | (8.70%) | (395.25%) | 0.00% |
| Free cash flow margin | (39.08%) | (318.63%) | 0.00% |
| Return on equity | (32.61%) | 266.76% | (51.96%) |
| Return on assets | (4.94%) | (79.08%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack